Porcine Acellular Dermal Matrix for the Treatment of Localized Gingival Recessions
1 other identifier
interventional
40
1 country
1
Brief Summary
Aim: The aim of this randomized clinical trial is to evaluate the use of the porcine acellular dermal matrix (PADM) for the treatment of RT1 localized gingival recessions. Material and methods: Forthy patients (n=20) with RT1 localized gingival recessions with height ranging from 3 to 5 mm with and at least, 2mm of keratinized tissue width will be selected to participate in the study. Patients will be allocated randomly in two treatment groups: Coronally advanced flap (CAF) or coronally advanced flap associated with the porcine acellular dermal matrix (CAF+ PADM). The clinical parameters evaluated at the baseline, 6 and 12 months will be: Plaque index (IPL); gingival index (GI); relative gingival recession height (RGRH); gingival recession width (GRW); probing depth (PD); relative clinical attachment level (RCAL); keratinized tissue height (KTH); keratinized tissue thickness (KTT); papilla height (PH). Evaluations will be made by the professional and the patient regarding dentin hypersensitivity (HD) (Schiff and VAS scales respectively), aesthetics (RES and VAS scales, respectively) and patient\'s centered outcomes, through the questionnaire referring to the OHIP-14. Descriptive statistical analysis will be expressed as mean ± standard deviation (SD), median, quartiles, percentages and confidence intervals (95% CI). To analyze the normality of the residue, the Shapiro-Wilk test will be performed. Then, the Wilcoxon test will be applied to compare the periodontal parameters and a quality of life, before and post-treatment. Correlations between parameters and dental hypersensitivity will be analyzed through Spearman\'s test. Key words: Gingival recession, Root coverage, Biomaterial, Acellular dermal matrix.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 10, 2022
CompletedFirst Submitted
Initial submission to the registry
August 17, 2023
CompletedFirst Posted
Study publicly available on registry
August 23, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2024
CompletedApril 2, 2025
March 1, 2025
2.3 years
August 17, 2023
March 27, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Recession change
Change of the gingival recession height
Baseline, 6 months and 12 months
Secondary Outcomes (1)
Thickness of keratinized tissue
Baseline, 6 months and 12 months
Study Arms (2)
Coronally advanced flap (CAF)
ACTIVE COMPARATORCoronally advanced flap associated with the porcine acellular dermal matrix (CAF+ PADM)
EXPERIMENTALInterventions
Coronally advanced flap associated with the porcine acellular dermal matrix for root coverage
Coronally advanced flap for root coverage
Eligibility Criteria
You may qualify if:
- RT1 localized gingival recessions with height ranging from 3 to 5 mm;
- mm or more of keratinized tissue width ;
- Probing depth less than 3mm;
- Plaque and gingival index less or equal to 20%.
You may not qualify if:
- Smokers;
- Pregnants;
- Nursing;
- Patients with diabetes mellitus or another condition that interfere in the tissue repair
- Patients who use drugs or medications that interfere in the tissue repair;
- Allergies to any composition of the devices of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Piracicaba Dental School, State University of Campinas
Piracicaba, São Paulo, 13414-903, Brazil
Related Publications (1)
Sangiorgio JPM, Neves FLDS, Rocha Dos Santos M, Franca-Grohmann IL, Casarin RCV, Casati MZ, Santamaria MP, Sallum EA. Xenogenous Collagen Matrix and/or Enamel Matrix Derivative for Treatment of Localized Gingival Recessions: A Randomized Clinical Trial. Part I: Clinical Outcomes. J Periodontol. 2017 Dec;88(12):1309-1318. doi: 10.1902/jop.2017.170126. Epub 2017 Jul 28.
PMID: 28753100BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD, Chair of Periodontolgy Area
Study Record Dates
First Submitted
August 17, 2023
First Posted
August 23, 2023
Study Start
September 10, 2022
Primary Completion
December 30, 2024
Study Completion
December 30, 2024
Last Updated
April 2, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share